Arkolith/Insider Trading/DCPH/Form 4

Martin Daniel C.

Chief Commercial OfficerDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Dec 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$27K
Net Open-Market Flow
-$27K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2023Sell(S)2K$15.37$27K49K
Dec 12, 2023Grant(A)6K——51K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-070383) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML